We next conducted rescue experiments with survivin and c-FLIPL to determine which protein was more important for enhancing the tumor-suppressive effect of miR-708 in renal cancer cells treated with anti-cancer drugs. This evidence concerns the gene BIRC5 and renal carcinoma.